Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

World Journal of Men's Health   2023.4

Trends in the age of hospitalized patients with urological cancers: A 17-year experience

Noritaka Ishii, Shingo Hatakeyama, Hikari Miura, Ryuma Tanaka, Takuya Oishi, Hirotaka Horiguchi, Shogo Hosogoe, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International Journal of Urology   2023.3

Combination of Muscle Quantity and Quality Is Useful to Assess the Necessity of Surveillance after a 5-Year Cancer-Free Period in Patients Who Undergo Radical Cystectomy: A Multi-Institutional Retrospective Study

Naoki Fujita, Masaki Momota, Hirotaka Horiguchi, Itsuto Hamano, Jotaro Mikami, Shingo Hatakeyama, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Shoji Nishimura, Kazuaki Yoshikawa, Chikara Ohyama

Cancers (Basel)   2023.2

Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer

Naoki Fujita, Shingo Hatakeyama, Kazutaka Okita, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

PLoS One   2023.2

Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study

Naoki Fujita, Masaki Momota, Yusuke Ozaki, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

World Journal of Men's Health   2023.1

Association between Advanced Glycation End-Products, Carotenoids, and Severe Erectile Dysfunction

Naoki Fujita, Mizuri Ishida, Takuro Iwane, Hiroyuki Suganuma, Mai Matsumoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tatsuya Mikami, Ken Itoh, Chikara Ohyama

World Journal of Men's Health   2023.1

Utility of the Age Discrepancy between Frailty-Based Biological Age and Expected Life Age in Patients with Urological Cancers

Kyo Togashi, Shingo Hatakeyama, Osamu Soma, Kazutaka Okita, Naoki Fujita, Toshikazu Tanaka, Daisuke Noro, Hirotaka Horiguchi, Nozomi Uemura, Takuro Iwane, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Cancers (Basel)   2022.12

Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction

Hikari Miura, Shingo Hatakeyama, Toshikazu Tanaka, Naoki Fujita, Hirotaka Horiguchi, Ryuma Tanaka, Daisuke Noro, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic Oncology   2022.12

Relationships of low-grade systemic inflammation and nutritional status with erectile dysfunction severity in men on dialysis

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Tomoko Hamaya, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Andrology   2022.11

Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids

Noritaka Ishii, Shingo Hatakeyama, Tohru Yoneyama, Ryuma Tanaka, Takuma Narita, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic Oncology   2022.10

Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

Scientific Reports   2022.8

Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guérin therapy

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

International Journal of Urology   2022.8

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy

Hiromichi Iwamura, Shingo Hatakeyama, Takuma Narita, Yusuke Ozaki, Sakae Konishi, Hirotaka Horiguchi, Hirotake Kodama, Yuta Kojima, Naoki Fujita, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Scientific Reports   2022.6

Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma

Kyo Togashi, Shingo Hatakeyama, Tohru Yoneyama, Tomoko Hamaya, Takuma Narita, Naoki Fujita, Hiromichi Iwamura, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

International journal of urology   2022.6

Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients

Tomoko Hamaya, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Hirotake Kodama, Takeshi Fujita, Reiichi Murakami, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hisao Saitoh, Shunji Narumi, Hirofumi Tomita, Chikara Ohyama

Scientific Reports   2022.4

Associations of impaired grip strength and gait function with the severity of erectile dysfunction in men undergoing dialysis: a cross-sectional study

Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama

The Aging Male   2021.12

Management of bladder cancer in older patients

Shingo Hatakeyama, Shintaro Narita, Kazutaka Okita, Takuma Narita, Hiromichi Iwamura, Naoki Fujita, Junichi Inokuchi, Yoshiyuki Matsui, Hiroshi Kitamura, Chikara Ohyama

Japanese journal of clinical oncology   2021.12

The cell surface hyaluronidase TMEM2 is essential for systemic hyaluronan catabolism and turnover

Yuki Tobisawa, Naoki Fujita, Hayato Yamamoto, Chikara Ohyama, Fumitoshi Irie, Yu Yamaguchi

The Journal of biological chemistry   2021.11

Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years

Kyo Togashi, Shingo Hatakeyama, Teppei Okamoto, Yuta Kojima, Hiromichi Iwamura, Naoki Fujita, Takuma Narita, Itsuto Hamano, Tomoko Hamaya, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Urologic oncology   2021.10

The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma

Kai Ozaki, Shingo Hatakeyama, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Hirotaka Horiguchi, Yoshiharu Okuyama, Naoki Fujita, Teppei Okamoto, Akiko Okamoto, Yuichiro Suzuki, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BJUI Compass   2021.8

Prognostic impact of eligibility for adjuvant immunotherapy in locally advanced urothelial cancer

Yuki Miura, Shingo Hatakeyama, Toshikazu Tanaka, Naoki Fujita, Hirotaka Horiguchi, Yoshiharu Okuyama, Yuta Kojima, Daisuke Noro, Noriko Tokui, Teppei Okamoto, Hayato Yamamoto, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

BJUI Compass   2021.8

The effect of number of treatment cycles of platinum-based first-line chemotherapy on maximum radiological response in patients with advanced urothelial carcinoma

Okita K, Hatakeyama S, Hagiwara K, Suzuki Y, Tanaka T, Noro D, Tokui N, Fujita N, Konishi S, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

2021.4

Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer

Horiguchi H, Hatakeyama S, Yoneyama T, Yoneyama MS, Tanaka T, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Yoshizawa T, Hashimoto Y, Kawaguchi T, Ohyama C

39 ( 4 )   238.e9 - 238.e17   2021.4

Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study)

Kodama H, Hatakeyama S, Momota M, Togashi K, Hamaya T, Hamano I, Fujita N, Kojima Y, Okamoto T, Yoneyama T, Yamamoto H, Yoshikawa K, Yoneyama T, Hashimoto Y, Ohyama C

39 ( 3 )   191.e1 - 191.e8   2021.3

Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Guérin therapy

Fujita N, Hatakeyama S, Okita K, Momota M, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

39 ( 3 )   191.e9 - 191.e16   2021.3

Impact of symptomatic recurrence on oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

39 ( 3 )   194.e9 - 194.e16   2021.3

Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study)

Iwamura H, Hatakeyama S, Momota M, Kojima Y, Narita T, Okamoto T, Fujita N, Hamano I, Togashi K, Hamaya T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

Translational andrology and urology   10 ( 3 )   1143 - 1151   2021.3

The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study)

Togashi K, Hatakeyama S, Kojima Y, Momota M, Narita T, Iwamura H, Hamano I, Hamaya T, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

39 ( 3 )   192.e7 - 192.e14   2021.3

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high-risk upper tract urothelial carcinoma: a multicentre retrospective study

Hamaya T, Hatakeyama S, Tanaka T, Kubota Y, Togashi K, Hosogoe S, Fujita N, Kusaka A, Tokui N, Okamoto T, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C

2021.1

Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer

Fujita N, Hatakeyama S, Okita K, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

39 ( 1 )   75.e9 - 75.e16   2021.1

Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study)

Hamaya T, Hatakeyama S, Momota M, Narita T, Iwamura H, Kojima Y, Hamano I, Fujita N, Okamoto T, Togashi K, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C

26 ( 1 )   199 - 206   2021.1

Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Mariya Y, Ohyama C

18 ( 5 )   e523 - e530   2020.10

Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor

Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

38 ( 10 )   795.e9 - 795.e17   2020.10

Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer

Fujita N, Hatakeyama S, Momota M, Kido K, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C

38 ( 8 )   684.e17 - 684.e24   2020.8

Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer

Okita K, Hatakeyama S, Momota M, Soma O, Hamano I, Tanaka T, Iwamura H, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Ohyama C

International journal of urology   27 ( 8 )   649 - 654   2020.8

Geriatric 8 screening of frailty in patients with prostate cancer

Momota M, Hatakeyama S, Soma O, Tanaka T, Hamano I, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Imai A, Yoshikawa K, Yoneyama T, Hashimoto Y, Ohyama C

International journal of urology   27 ( 8 )   642 - 648   2020.8

Preoperative chronic kidney disease predicts poor prognosis in patients with primary non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor

38 ( 8 )   684.e1 - 684.e8   2020.8

The impact of microalbuminuria on overactive bladders: Results from a community-based four-year longitudinal study in Japan

Teppei Okamoto, Shingo Hatakeyama, Masataka Ando, Jung Songee, Atsushi Imai, Itsuto Hamano, Naoki Fujita, Akiko Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama

Neurourology and urodynamics   2020.6

Relationship between frailty and lower urinary tract symptoms among community-dwelling adults

Soma O, Hatakeyama S, Imai A, Matsumoto T, Hamano I, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C

Lower urinary tract symptoms   12 ( 2 )   128 - 136   2020.5

Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma

Suppanuntaroek S, Hatakeyama S, Fujita N, Kubota Y, Suzuki Y, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Mori K, Imai A, Yoneyama T, Hashimoto Y, Ohyama C

International journal of clinical oncology   25 ( 2 )   362 - 369   2020.2

C-reactive protein/albumin ratio is a predictive factor for prognosis in patients with metastatic renal cell carcinoma

Konishi S, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Hamano I, Fujita N, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C

International journal of urology   26 ( 10 )   992 - 998   2019.10

Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers

Soma O, Hatakeyama S, Okamoto T, Fujita N, Hamano I, Tanaka T, Momota M, Yoneyama T, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Saitoh H, Nakaji S, Suzuki T, Ohyama C

Medical oncology   36 ( 10 )   88   2019.9

Robot-assisted radical cystectomy in a patient with muscle-invasive bladder cancer following radiotherapy for prostate cancer

Kubota Y, Hatakeyama S, Hashimoto T, Fujita N, Okamoto T, Suzuki Y, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C

IJU case reports   2 ( 4 )   236 - 239   2019.7

Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma

Kazutaka Okita, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Naoki Fujita, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama

Clinical genitourinary cancer   2019.6

Platinum-based Neoadjuvant Chemotherapy Improves Oncological Outcomes in Patients with Locally Advanced Upper Tract Urothelial Carcinoma

Shogo Hosogoe, Shingo Hatakeyama, Ayumu Kusaka, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

2018.12

Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer

Okita K, Hatakeyama S, Fujita N, Konishi S, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Ito H, Yoshikawa K, Koie T, Ohyama C.

Medical Oncology   2018.11

Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis

Konishi S, Hatakeyama S, Tanaka T, Ikehata Y, Tanaka T, Fujita N, Ishibashi Y, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Masumori N, Kitamura H, Ohyama C.

2018.11

Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution

Naoki Fujita, Takuya Koie, Yasuhiro Hashimoto, Takuma Narita, Yuki Tobisawa, Toshikazu Tanaka, Daisuke Noro, Masaaki Oikawa, Kazuhisa Hagiwara, Tohru Yoneyama, Atsushi Imai, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Chikara Ohyama

International urology and nephrology   2018.11

Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma

Koichi Kido, Shingo Hatakeyama, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi, Chikara Ohyama

International journal of clinical oncology   2018.8

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers

Soma O, Hatakeyama S, Okamoto T, Fujita N, Matsumoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C

Oncotarget   9 ( 25 )   17396 - 17405   2018.4

Impact of bacillus Calmette-Guérin therapy of upper urinary tract carcinoma in situ: comparison of oncological outcomes with radical nephroureterectomy

Horiguchi H, Yoneyama T, Hatakeyama S, Tokui N, Sato T, Fujita N, Yamamoto H, Tobisawa Y, Yoneyama T, Hashimoto Y, Koie T, Yoshikawa K, Narita S, Kawaguchi T, Ohyama C

35 ( 4 )   41   2018.2

Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava

Yoshimi Tanaka, Shingo Hatakeyama, Shogo Hosogoe, Toshikazu Tanaka, Itsuto Hamano, Ayumu Kusaka, Hiromich Iwamura, Naoki Fujita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama

International journal of clinical oncology   2018.2

Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution

Fujita N, Koie T, Ohyama C, Tanaka Y, Soma O, Matsumoto T, Yamamoto H, Imai A, Tobisawa Y, Yoneyama T, Hatakeyama S, Hashimoto Y

International journal of clinical oncology   22 ( 6 )   1087 - 1093   2017.12

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study

Kubota Y, Hatakeyama S, Tanaka T, Fujita N, Iwamura H, Mikami J, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Sasaki A, Kawaguchi T, Ohyama C

Oncotarget   8 ( 60 )   101500 - 101508   2017.11

Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma

Kodama H, Hatakeyama S, Fujita N, Iwamura H, Anan G, Fukushi K, Narita T, Tanaka T, Kubota Y, Horiguchi H, Momota M, Kido K, Matsumoto T, Soma O, Hamano I, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Sasaki A, Kawaguchi T, Sato M, Ohyama C

Oncotarget   8 ( 47 )   83183 - 83194   2017.10

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study

Go Anan, Shingo Hatakeyama, Naoki Fujita, Hiromichi Iwamura, Toshikazu Tanaka, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Makoto Sato, Chikara Ohyama

Oncotarget   2017.9

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer

Kusaka A, Hatakeyama S, Hosogoe S, Hamano I, Iwamura H, Fujita N, Fukushi K, Narita T, Hagiwara K, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Ito H, Yoshikawa K, Kawaguchi T, Ohyama C

8 ( 39 )   65492 - 65505   2017.9

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer

Itsuto Hamano, Shingo Hatakeyama, Hiromichi Iwamurau, Naoki Fujita, Ken Fukushi, Takuma Narita, Kazuhisa Hagiwara, Ayumu Kusaka, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama

2017.5

Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer

Medical oncology   2017.5

Implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism

International journal of urology   2016.5

BCG菌株交替療法についての基礎的検討

盛　和行，飛澤悠葵，米山　徹，岩村大径，佐藤天童，藤田尚紀，三上穣太郎，今井　篤，畠山真吾，米山高弘，橋本安弘，古家琢也，大山　力

泌尿器外科   2016

ハイリスク前立腺癌に対する術前内分泌化学療法後のロボット支援前立腺全摘除術の治療成績

米山高弘，小島由太，佐藤天童，岩村大径，藤田尚紀，三上穣太郎，杉山尚樹，飛澤悠葵，米山　徹，今井　篤，畠山真吾，橋本安弘，古家琢也，大山　力

泌尿器外科   2015

Tubulocystic renal cell carcinoma in the left kidney: a case report

Journal of medical case reports   2014.7

Preoperative butyrylcholinesterase level as an independent predictor of overall survival in clear cell renal cell carcinoma patients treated with nephrectomy

The Scientific World Journal   2014.3

Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis

BMC Nephrology   2013.10

[Local recurrence of pheochromocytoma associated with von Hippel-Lindau disease 26 years after bilateral adrenalectomy : a case report].

Hinyokika kiyo. Acta urologica Japonica   59 ( 7 )   427 - 30   2013.7

両側副腎褐色細胞腫摘除術26年後に局所再発した von Hippel-Lindau 病随伴褐色細胞腫の1例

藤田尚紀，三上穣太郎，村澤洋美，岡本亜希子，今井　篤，畠山真吾，石村大史，米山高弘，古家琢也，神村典孝，大山　力，諸橋聡子，鬼島　宏

泌尿器科紀要   2013

当科における整体腎移植ドナー腎再手術の検討

米山高弘，佐藤天童，藤田尚紀，小島由太，三上穣太郎，福士　謙，岩村大径，村澤洋美，飛澤悠葵，米山　徹，岡本亜希子，山本勇人，今井　篤，畠山真吾，盛　和行，橋本安弘，古家琢也，大山　力

腎移植・血管外科   2012

Advancements in Urology 2011 : A Japanese Urological Association (JUA)/American Urological Association (AUA) Symposium

NAITO Seiji, EGAWA Shin, NAKAGAWA Masayuki, KAKEHI Yoshiyuki, FLANIGAN Robert C, HAYASHI Tetsutaro, OHARA Shinya, TEISHIMA Jun, SHOJI Koichi, SENTANI Kazuhiro, OUE Naohide, YASUI Wataru, MATSUBARA Akio, SAKAMOTO Shinichi, KAWAMURA Koji, IMAMOTO Takashi, NIHEI Naoki, KYPRIANOU Natasha, ICHIKAWA Tomohiko, HASHIMOTO Kohei, MASUMORI Naoya, TANAKA Toshiaki, KITAMURA Hiroshi, TSUKAMOTO Taiji, KIMURA Kyosuke, TSUKII Toyonori, KAMIHIRA Osanu, SASSA Naoto, KOMATSU Tomonori, HATTORI Ryohei, GOTOH Momokazu, SHIMIZU Shinjiro, JO Yoshimasa, YOKOYAMA Teruhiko, KAIFU Mikako, HARA Ryoei, FUJII Tomohiro, MIYAJI Yoshiyuki, NAGAI Atsushi, TSUZUKI Shunsuke, KIDO Masahito, YAMAMOTO Toshihiro, MIKI Jun, KIMURA Takahiro, MIKI Kenta, AOKI Manabu, EGAWA Shin, NAKANISHI Juro, WADA Yoshihiro, TAKAHASHI Wataru, HONDA Jiro, ETO Masatoshi, KITAGAWA Yasuhide, SHIGEHARA Kazuyoshi, MIWA Sotaro, MIYAGI Toru, KADONO Yoshifumi, KONAKA Hiroyuki, MIZOKAMI Atsushi, NAMIKI Mikio, KATO Takuma, YANO Toshifumi, HIRAMA Hiromi, UETSUKI Hiotsugu, TSUNEMORI Hiroyuki, INUI Masashi, SUGIMOTO Mikio, KAKEHI Yoshiyuki, ICHIMATSU Keisuke, IIDA Hiroaki, MORII Akihiro, YASUDA Kenji, WATANABE Akihiko, NOZAKI Tetsuo, KOMIYA Akira, FUSE Hideki, MAKI Yoshio, KURUMA Hidetoshi, GUST Kilian, MATSUMOTO Hiroaki, ZOUBEIDI Amina, FAZLI Ladan, LODDICK Sarah, BROOKS Nigel, GLEAVE Martin, CHOI Han Y, PARK Jong W, PARK Seo Y, LEE Hyun M, JEON Seong S, SEO Seong I, PARK Byung K, HIRAI Kenichi, NOMURA Takeo, YAMASAKI Mutsushi, MATSUBARA Takanori, SATO Fuminori, MIMATA Hiromitsu, SENO Yasuyuki, KATO Masao, MITA Koji, NOMURA Takeo, HUANG Wen-Chin, CHUNG Leland WK, MIMATA Hiromitsu, MURAKAMI Masaya, MIKI Jun, KIMURA Takahiro, HATANO Takashi, EGAWA Shin, MATSUTA Yosuke, AKINO Hironobu, NAMIKI Mikio, FUSE Hideki, SUZUKI Kouji, YOKOYAMA Osamu, ONIZUKA Chie, KAMIMURA Toshio, NAGANO Masafumi, YAMAGUCHI Takanori, KAMOTO Toshiyuki, HASHIMOTO Jiro, TAKAHASHI Satoshi, UEHARA Teruhisa, KURIMURA Yuichiro, TSUKAMOTO Taiji, FUKUMOTO Kazuhiko, YOKOYAMA Teruhiko, KAIFU Mikako, HARA Ryoei, FUJII Tomohiro, JO Yoshimasa, MIYAJI Yoshiyuki, NAGAI Atsushi, TORIMOTO Kazumasa, TAKAMI Takeshi, HIRAYAMA Akihide, KUWADA Masaomi, KAGEBAYASHI Yoriaki, SAMMA Shoji, FUJIMOTO Kiyohide, HIRAO Yoshihiko, ISHIURA Yoshiyuki, YAEGASHI Hiroshi, KOSHIDA Kiyoshi, MAEDA Yoshiko, SEKIGUCHI Yuki, SHITAMURA Takahiro, INOUE Katumi, NOSE Kiyotaka, KAMOTO Toshiyuki, HAYAMI Hiroshi, ENOKIDA Hideki, NAKAGAWA Masayuki, NAITO Seiji, MATSUMOTO Tetsuro, UOZUMI Jiro, MIMATA Hiromitsu, TAKEI Mineo, YOKOYAMA Teruhiko, FUKUMOTO Kazuhiko, HARA Ryoei, FUJII Tomohiro, JO Yoshimasa, MIYAJI Yoshiyuki, NAGAI Atsushi, KAMIMURA Noritaka, FUJITA Naoki, TOKUI Noriko, OKAMOTO Teppei, IMANISHI Kengo, SUGIYAMA Naoki, IMAI Atsushi, OHYAMA Chikara, YOSHINO Hirofumi, CHIYOMARU Takeshi, ENOKIDA Hideki, KAWAKAMI Kazumori, TATARANO Shuichi, NISHIYAMA Kenryu, SEKI Naohiko, NAKAGAWA Masayuki, TATARANO Shuichi, CHIYOMARU Takeshi, KAWAKAMI Kazumori, ENOKIDA Hideki, YOSHINO Hirofumi, NISHIYAMA Kenryu, SEKI Naohiko, NAKAGAWA Masayuki, SEGAWA Takehiko, TAKAHASHI Takeshi, MATSUMOTO Keiyu, SUMIYOSHI Takayuki, UTSUNOMIYA Noriaki, MUGURUMA Koei, KAWAKITA Mutsushi, IKEDA Hiroshi, NOMURA Masayoshi, SHOU Takehiko, ISHIKAWA Kaori, KASHIWAGI Eiji, DEJIMA Takashi, SANEFUJI Hayato, OKUMURA Kouji, YANAGISAWA Takafumi, MIKI Jun, ISHII Gen, BANDO Shigehiro, MIKI Kenta, EGAWA Shin, TANAKA Nobuyuki, KIKUCHI Eiji, MATSUMOTO Kazuhiro, MIYAJIMA Akira, NAKAGAWA Ken, OYA Mototsugu, ISHII Gen, MIKI Jun, TABATA Ryuji, KIMURA Takahiro, EGAWA Shin, KAWAMURA Koji, SAKAMOTO Shinichi, UTSUMI Takanobu, IMAMOTO Takashi, NIHEI Naoki, ICHIKAWA Tomohiko

International journal of urology   18 ( 5 )   388 - 408   2011.5